COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
09.05.2022 - London, UK – 9 May 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced it will be funding an ... Seite 1